Clinical trial
Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent…
NCT00004192 · University of Nebraska, Other · Completed
Key facts
| NCT number | NCT00004192 |
|---|---|
| Title | Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma |
| Official title | A Randomized, Multicenter, Open-Label Study of Single Dose Filgrastim-SD/01 Versus Daily Filgrastim Following ESHAP Chemotherapy for Non-Hodgkin's Lymphoma |
| Lead sponsor | University of Nebraska, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Neutropenia |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, pegfilgrastim, cisplatin, cytarabine, etoposide, methylprednisolone |
| Enrollment | 60 |
| Start date | May 1, 2000 |
| Primary completion | Feb 1, 2001 |
| Completion | Mar 16, 2001 |
| First posted | Jun 25, 2004 |
| Last update posted | Dec 27, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: